Archive for December 10th, 2011

Weekly Summary of key pharma events – week ended 12/9/11

Dec 10, 2011 No Comments by

Affymax, Inc. (Nasdaq:AFFY) received positive recommendation from the FDA Oncologic Drugs Advisory Committee (ODAC) for its  New Drug Application (NDA) of peginesatide for the proposed treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis was reviewed. The panel was asked to consider the following question, “Considering the safety issues associated with […]

Articles Read more